Table 2.
Demographic and health characteristics, as well as baseline assessments of the study participants (n = 45).
| Characteristics | Study participants (n = 45) |
|---|---|
| Demographic information | |
| Sex, n (%) | |
| Female | 29 (64.4%) |
| Male | 16 (35.6%) |
| Age, median (IQR) | 46 (40-51) |
| Nationalitya, n (%) | |
| Swiss | 34 (75.6%) |
| German | 6 (13.3%) |
| Italian | 2 (4.4%) |
| Other | 3 (6.7%) |
| Marital status, n (%) | |
| Single | 12 (26.7%) |
| Married | 23 (51.1%) |
| Separated | 1 (2.2%) |
| Divorced | 7 (15.6%) |
| Widowed | 2 (4.4%) |
| Education, n (%) | |
| Mandatory school not completed (or up to and including 7th grade) | 2 (4.4%) |
| Apprenticeship or secondary education completed (i.e. Matura schools or intermediate diploma schools) | 25 (55.6%) |
| Higher professional education, applied university or university completed | 18 (40%) |
| Employment, n (%) | |
| Working full time | 5 (11.1%) |
| Working more than 50% but less than 100% | 5 (11.1%) |
| Working 50% or less | 17 (37.8%) |
| Not working | 18 (40%) |
| Health information | |
| Multiple sclerosis type, n (%) | |
| Relapsing-remitting multiple sclerosis | 18 (40%) |
| Secondary-progressive multiple sclerosis | 19 (42.2%) |
| Primary-progressive multiple sclerosis | 8 (17.8%) |
| Multiple sclerosis duration, median (IQR) | 11 (5-21) |
| Expanded Disability Status Scale, median (IQR) | 4 (3.5-6.0) |
| Expanded Disability Status Scale, n (%) | |
| 0–3.5 | 13 (28.9%) |
| 4–5.5 | 19 (42.2%) |
| ≥6 | 13 (28.9%) |
| Time since last relapse in years, median (IQR) | 3 (1-5) |
| Missing information | 8 |
| Body mass index, median (IQR) | 24 (21-28) |
| Missing information | 4 |
| Comorbiditiesa, n (%) | |
| None | 18 (40%) |
| Hypertension | 5 (11.1%) |
| Depression | 5 (11.1%) |
| Skin diseases (e.g., acne) | 4 (8.9%) |
| Orthopedic diseases (e.g., joint or back pain) | 4 (8.9%) |
| Diabetes type II | 3 (6.7%) |
| Migraine | 2 (4.4%) |
| Hypothyroidism | 2 (4.4%) |
| Otherb | 9 (20%) |
| Baseline assessments | |
| Change in the amount of sport practiced after the MS diagnosis, n (%) | |
| Less | 27 (60%) |
| Same amount | 2 (4.4%) |
| More | 15 (33.3%) |
| Missing information | 1 (2.2%) |
| Barriers to Health Promoting Activities for Disabled Persons Scale (score range 18-72), median (IQR) | 28 (26-32) |
| International Physical Activity Questionnaire—Short Form, median (IQR) of total active minutes per day in the last seven days | 155 (90-240) |
| Missing information | 4 |
| 12-Item Multiple Sclerosis Walking Scale (score range 0-100; refers to the last two weeks), median (IQR) | 62.5 (39.6-81.2) |
| Missing information | 2 |
| Fatigue Scale for Motor and Cognitive Functions (score range 20-100; refers to the everyday life), n (%) | |
| No fatigue (score <43) | 4 (8.9%) |
| Mild fatigue (score ≥43) | 15 (33.3%) |
| Moderate fatigue (score ≥53) | 3 (6.7%) |
| Severe fatigue (score ≥63) | 23 (51.1%) |
| Fatigue Scale for Motor and Cognitive Functions–Cognitive fatigue (score range 10-50; refers to the everyday life), n (%) | |
| No cognitive fatigue (score <22) | 18 (40%) |
| Mild cognitive fatigue (score ≥22) | 4 (8.9%) |
| Moderate cognitive fatigue (score ≥28) | 9 (20%) |
| Severe cognitive fatigue (score ≥34) | 14 (31.1%) |
| Fatigue Scale for Motor and Cognitive Functions–Motor fatigue (score range 10-50; refers to the everyday life), n (%) | |
| No motor fatigue (score <22) | 1 (2.2%) |
| Mild motor fatigue (score ≥22) | 5 (11.1%) |
| Moderate motor fatigue (score ≥27) | 6 (13.3%) |
| Severe motor fatigue (score ≥32) | 33 (73.3%) |
| General Self-Efficacy Scale (score range 10-40), median (IQR) | 30 (28-33) |
| Patient Health Questionnaire-8 (score range 0-24; refers to the current state), n (%) | |
| No significant depressive symptoms (score <5) | 19 (42.2%) |
| Mild depressive symptoms (score ≥5) | 17 (37.8%) |
| Moderate depressive symptoms (score ≥10) | 6 (13.3%) |
| Moderately severe depressive symptoms (score ≥15) | 2 (4.4%) |
| Missing information | 1 (2.2%) |
| EuroQol Visual Analogue Scale (value, 0-100 scale; refers to “today”), median (IQR) | 60 (50-75) |
| Missing information | 1 |
| EuroQol 5-Dimension 5-Level weighted by the French value set (0-100 scale; refers to “today”), median (IQR) | 63.5 (46.7-73.0) |
| Missing information | 2 |
| How bad was your pain when it was at its lowest during the last 7 days? (0-10 scale), median (IQR) | 0 (0-1) |
| How bad is your pain right now? (0-10 scale), median (IQR) | 1 (0-3.2) |
| Missing information | 5 |
| How bad was your pain when it was at its worst during the last 7 days? (0-10 scale), median (IQR) | 3 (0-6) |
| Walking endurance: 6 Min Walk Test [meter], median (IQR) | 329.5 (205-420.5) |
| Missing information | 1 |
| Walking speed: 10 Meter Walk Test [second], median (IQR) | 9 (7-13) |
| Missing information | 0 |
| Balance and dynamic functional mobility: Timed Up and Go [second], median (IQR) | 10 (8-14) |
| Number of days in the rehabilitation clinic, median (IQR) | 22 (18-26) |
a
Multiple answers possible.
b
Asthma, diabetes type I, osteoporosis, psoriasis, cancer, rheumatic diseases, elevated cholesterol, colitis ulcerosa, fibromyalgia, shingles, Meniere's disease, cerebellar syndrome.